Lyell Immunopharma, Inc. ($LYEL)
ARCH Venture Partners IX, LLC โ 10% Owner
Shares
2,321,262
Price
$10.77
Total Value
$24,999,991.74
P&L
+39.3% (+$9,818,938.26)
Nearby Earnings
Nov 10, 2026
EPS:Est: -2.06
Revenue:Est: $4.60K
Transaction Details
| Insider | ARCH Venture Partners IX, LLC |
|---|---|
| Title | 10% Owner |
| Transaction Date | Nov 4, 2026 |
| Transaction Code | P Purchase |
| Acquired/Disposed | Acquired |
| Security | Common Stock |
| Direct/Indirect | Indirect |
| Nature of Ownership | See Footnote |
| Filing Date | Nov 5, 2026 |
| Shares Purchased | 2,321,262 |
| Price per Share | $10.77 |
| Total Value | $24,999,991.74 |
| Shares Owned After | 3,747,790 |
| Derivative | No |
| Accession Number | 0001012975-26-001014 |
| Document | View SEC Filing |